In recent years, cannabidiol (CBD) has surged into the spotlight as a potential game-changer in the realm of healthcare, particularly concerning neurological disorders. Derived from the hemp plant, CBD is a non-psychoactive compound, meaning it doesn’t produce the “high” associated with hemp use. This attribute has spurred significant interest